Skip to main content
. 2022 May 25;14(11):2621. doi: 10.3390/cancers14112621

Table 1.

Demographic statistics. Number of CTC-positive (CTC+) and CTC-negative (CTC-) blood samples divided according to clinical variables of the patients at primary diagnosis. p-values were calculated using Welch’s two-sided t-test and the multinomial exact test. CTC values were not available for three patients.

At Primary Diagnosis N = 60 CTC+ (n = 20) CTC− (n = 37) p Value
Age (years)
Mean 52 55 49 0.0848
Range 28–76 39–76 28–75
ER
Positive 60 20 37 -
PR
Positive 54 18 34 0.9411
Negative 6 2 3
ERBB2
Positive 8 2 5 0.8235
Negative 43 15 26
Grade
G1–2 29 11 18 0.4656
G3 10 2 7
T-stage
1–2 34 12 21 0.7028
3–4 12 3 8
N-stage
0 12 4 7 0.9613
1–3 33 11 21
initial M-stage
0 13 3 10 0.8683
1 12 2 9
At blood draw N = 97 CTC+ (n = 31) CTC− (n = 66)
Age (years)
Mean 62 63 62 0.8006
Range 34–86 39–86 34–80
Therapy
Naïve 9 4 5 0.5536
Endocrine 37 10 27
Chemo 51 17 34
Stage
Stable 37 7 30 0.0476
Progression 38 17 21